Vaccinia expression of Mycobacterium tuberculosis-secreted proteins: Tissue plasminogen activator signal sequence enhances expression and immunogenicity of M. tuberculosis Ag85

Microbes and Infection

Volumn 2, Issue 14, 2000, Pages 1677-1685

  Malin, Adam S ^a   Huygen, Kris ^b   Content, Jean ^b   Mackett, Michael ^c   Brandt, Lisa ^d   Andersen, Peter ^d   Smith, Steven M ^a   Dockrell, Hazel M ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b PASTEUR INSTITUTE OF BRUSSELS   (Belgium)

^c CHRISTIE HOSPITAL   (United Kingdom)

^d STATENS SERUM INSTITUT   (Denmark)

Author keywords

Mycobacterium tuberculosis; Signal sequence; Vaccinia

Indexed keywords

GAMMA INTERFERON; MYCOBACTERIUM ANTIGEN; MYCOBACTERIUM TUBERCULOSIS ANTIGEN 85; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; GLYCOSYLATION; IMMUNOGENICITY; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SEQUENCE ANALYSIS; SPLEEN CELL; T LYMPHOCYTE; VACCINE PRODUCTION; VACCINIA VIRUS; VIRUS RECOMBINANT;

ACTINOBACTERIA (CLASS); ANIMALIA; EUKARYOTA; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; UNCULTURED ACTINOMYCETE; VACCINIA; VACCINIA VIRUS;

EID: 0033635475     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(00)01323-X     Document Type: Article

References (50)

1. Tuberculosis: Commentary on a reemergent killer
2. Modern vaccines. Mycobacterial diseases
3. The Tuberculosis Prevention Trial, Trial of BCG vaccines in South India for tuberculosis prevention
4. Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi
5. Designing a vaccine for tuberculosis
6. Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Myobacterium tuberculosis
7. T cell response to Myobacterium tuberculosis
8. Identification of immunodominant antigens during infection with Mycobacterium tuberculosis
9. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine
10. Mapping of TH1 helper T-cell epitopes on major secreted mycobacterial antigen 85A in mice infected with live Mycobacterium boris BCG
11. Specificity of a protective memory immune response against Mycobacterium tuberculosis
12. Purification and characterization of low-molecular-mass T cell antigen secreted by Mycobacterium tuberculosis
13. Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins
14. Human alveolar T lymphocyte responses to Mycobacterium tuberculosis antigens: Role for CD4+ and CD8+ cytotoxic T cells and relative resistance of alveolar macrophages to lysis
15. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection
16. Immune response to Mycobacterium bovis bacille Calmette Guerin infection in major histocompatibility complex class I- and II-deficient knock-out mice: Contribution of CD4 and CD8 T cells to acquired resistance
17. A single mycobacterial protein (hsp 65) expressed by a transgenic antigen-presenting cell vaccinates mice against tuberculosis
18. Vaccination against tuberculosis by DNA injection
19. Vaccination with recombinant vaccinia viruses protects mice against Mycobacterium tuberculosis infection
20. Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4+ and CD8+ T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection
21. Protection against Mycobacterium tuberculosis infection by CD8+ T cells requires the production of gamma interferon
22. The course of Mycobacterium tuberculosis infection in the lungs of mice lacking expression of either perforin- or granzyme-mediated cytolytic mechanisms
23. Perforin, a cytotoxic molecule which mediates cell necrosis is not required for the early control of mycobacterial infection in mice
24. Stimulation of human peripheral blood mononuclear cells with live Mycobacterium bovis BCG activates cytolytic CD8+ T cells in vitro
25. Characterisation of human Mycobacterium bovis bacille Calmette-Guerin reactive CD8+ T cells
26. Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis
27. Activation of human CD8+ abTCR+ cells by Mycobacterium tuberculosis via an alternate class I MHC antigen-processing pathway
28. Characterisation of human CD8+ T cells reactive Mycobacterium tuberculosisinfected antigen presenting cells
29. Poxvirus-based vectors as vaccine candidates
30. Construction and characterisation of vaccinia virus recombinants
31. Cloning, sequence determination, and expression of a 32-kilodalton-protein gene of Mycobacterium tuberculosis
32. The genes coding for the antigen 85 complexes of Mycobacterium tuberculosis and Mycobacterium bovis BCG are members of a gene family: Cloning, sequence determination, and genomic organization of the gene coding for antigen 85-C of M. tuberculosis
33. Nucleotide sequence of the 85B-protein gene of Mycobacterium bovis BCG and Mycobacterium tuberculosis
34. Dissection of Mycobacterium tuberculosis antigens using recombinant DNA
35. The structure of the human tissue-type plasminogen activator gene: Correlation of intron and exon structures to functional and structural domains
36. Isoelectrophoretic characterization of protein antigens present in mycobacterial culture filtrates and recognized by monoclonal antibodies directed against the Mycobacterium bovis BCG antigen 85 complex
37. Proteins released from Mycobacterium tuberculosis during growth
38. Purification, characterization and identification of a 32 kDa protein antigen of Mycobacterium bovis BCG
39. Spleen cell cytokine secretion in Mycobacterium bovis BCG-infected mice
40. H-2-linked control of in vitro gamma interferon production in response to a 32-kilodalton antigen (P32) of Mycobacterium bovis bacillus Calmette-Guerin
41. Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex
42. B-cell epitopes and quantification of the ESAT-6 protein of Mycobacterium tuberculosis
43. Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells
44. Immunogenicity of DNA vaccines expressing tuberculosis proteins fused to tissue plasminogen activator signal sequences
45. Immunogenicity and protective efficacy of DNA vaccines encoding secreted and non-secreted forms of Mycobacterium tuberculosis Ag85A
46. Role of CD8+ T cells in mycobacterial infections
47. CD4+ T cells contain Mycobacterium tuberculosis infection in the absence of CD8+ T cells, in mice vaccinated with DNA encoding Ag85A
48. Mycobacterium bovis bacille Calmette-Guerin strains secreting listeriolysin of Listeria monocytogenes
49. Introduction of protein or DNA delivered via recombinant Salmonella typhimurium into the major histocompatibility complex class I presentation pathway of macrophages